2019 Agenda

Cambridge Healthtech Institute’s 14th Annual

Neurotech Investing and Partnering Conference

Advancing Neurotechnology through Investment and Collaboration

May 21-22, 2019

 

The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.

 

Coverage will include, but is not limited to:

 

  • Investing in Neurotech Panel
  • Internal and External Research and Development
  • Partnering and Licensing in Neurotech Panel
  • Treatments for Alzheimer’s and Cognitive Disorders
  • Next Generation Psychiatry
  • Frontiers in Neurotechnology

 

If you would like to express your interest in participating as a panelist or speaker at this meeting, please click here.

 

The deadline for priority consideration is December 1, 2018.

 

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Carla M. Lema Tome, MBA, PhD

Conference Producer

Cambridge Healthtech Institute

Phone: 321.626.0558
Email: clematomme@cambridgeinnovationinstitute.com

 

For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781.247.6286
Email: reymael@healthtech.com